Skip to content
Plan your launch

Services · Market access

A reimbursement route for each country you enter.

For medtech, diagnostics, digital health, and healthcare AI companies past approval. We map who pays, plan the evidence they ask for, and lead the route; our reimbursement partners prepare the filings.

HealthSeed

Market access

  • 1Senior Partner leads
  • 4steps to a filed application
  • 35+Expert Community specialists

What you get

A payer route your board can fund.

The Launchpad’s market access phase, available on its own.

  • Payer map per country

    Who decides payment for your product, who applies, and on what evidence, for each target country.

  • Evidence plan for payers

    The clinical and health economic evidence payers ask for, and what you can build once for several countries.

  • Route and sequence

    National routes, joint clinical assessment where it applies, and which country to file first, with filings by our reimbursement partners.

How it runs

Four steps from payer map to filed application.

A Senior Partner leads the route. Reimbursement partners prepare and file the applications, confirmed at kickoff, subject to mutual agreement.

  1. 01

    Map

    Who decides payment for your product in each target country, and who applies.

  2. 02

    Plan the evidence

    The clinical and health economic evidence those payers ask for, built once where possible.

  3. 03

    Choose the route

    National route, joint clinical assessment where it applies, and the order of countries.

  4. 04

    Price and file

    A price position per channel, and applications prepared and filed by our reimbursement partners.

Read the evidence first

The market access chapters of From CE Mark to Revenue.

Our free reference book sets out the rules each step rests on, with every source linked.

  • EU HTA Regulation: joint clinical assessment

    Which devices and IVDs fall under joint clinical assessment, and the dossier that follows.

    Read chapter 12
  • Device and IVD reimbursement by EU country

    How national routes decide payment, who applies, and who pays.

    Read chapter 13
  • Health economic evidence for medical devices

    Evidence a device company can build once for several countries.

    Read chapter 14

What happens next

  1. You tell us the product, its approval, and the countries you want
  2. A Senior Partner replies with a proposed scope
  3. You receive a written proposal with fees

Next step

Talk to a Senior Partner about market access.

Bring us in for this step alone, or as part of the Launchpad. A Senior Partner reads every enquiry and replies.

Talk to a Senior Partner